PALI Palisade Bio, Inc. - Common Stock
$2.16
价格 · 八月 19, 2026
截至...的财报数据 八月 10, 2026
52周区间
$1–$3
70% of range
分析师评级
BUY
16 analysts
目标价
$10
+373% upside
P/E (TTM)
-7.2
ROE
-25.4%
净利润率
—
PALI 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.16
市值
$344M
P/E (TTM)
-7.2
每股收益 (TTM)
$-0.30
营收 (TTM)
$0
股息收益率
—
ROE
-25.4%
负债/权益
—
52周区间
$1 – $3
PALI 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2016-12-31
→
2025-12-31
EPS
$-0.30
2020-12-31
→
2025-12-31
自由现金流
—
2016-12-31
→
2024-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
PALI
同行中位数
P/E (TTM)
-7.2
6.1
P/B (市净率)
2.7
2.2
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
PALI
同行中位数
ROA
-23.1%
-50.0%
ROE
-25.4%
-44.8%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
PALI
同行中位数
Current Ratio (流动比率)
29.0
5.9
Quick Ratio (速动比率)
28.8
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
PALI
同行中位数
Revenue CAGR 3Y (营收3年复合年增长率)
164.4%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
PALI
同行中位数
PALI 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
16 位分析师
- 强烈买入 6 37.5%
- 买入 9 56.2%
- 持有 1 6.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
9 位分析师 · 2026-08-17
中位数
$8.00
平均值
$10.22
← 低于所有目标
$2.16
最低
$5.00
最高
$25.00
中位数目标
$8.00
+270.4%
平均目标
$10.22
+373.2%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.09%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.05 | $-0.05 | 0.00% |
| 2026年3月31日 | $-0.05 | $-0.04 | -0.01% |
| 2025年12月31日 | $-0.08 | $-0.08 | 0.00% |
| 2025年9月30日 | $-0.38 | $-0.28 | -0.10% |
| 2025年6月30日 | $-0.58 | $-0.57 | -0.01% |
| 2025年3月31日 | $-0.47 | $-0.71 | 0.24% |
| 2024年12月31日 | $-1.55 | $-2.03 | 0.48% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PALI | $375M | -7.8 | — | — | -25.4% | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| RCKT | — | — | — | — | — | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $250.0K | $0 | · | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| R&D Expense | · | $16M | · | · | · | $2M | $4M | $4M | $8M | $13M | $13M | $8M | |
| SG&A Expense | $8M | $6M | $6M | $9M | $9M | $6M | $5M | $5M | $5M | $7M | $7M | $9M | |
| Operating Expenses | $18M | $15M | $13M | $16M | $42M | $9M | $9M | $9M | $14M | $21M | $19M | $17M | |
| Operating Income | $-18M | $-15M | $-13M | $-16M | $-42M | $-9M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M | |
| Interest Expense | · | $12.0K | $15.0K | $13.0K | $2M | $235.0K | $8.9K | $7.7K | $159.1K | $1M | $2M | $2M | |
| Interest Income | · | · | · | · | · | $33.5K | $67.7K | $78.8K | $70.3K | $58.8K | $69.5K | $67.7K | |
| Other Non-op | $1M | $433.0K | $785.0K | $3M | $47.0K | $13.0K | $280.0K | $3M | $-2M | $-437.8K | $-2M | $0 | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $1.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| EPS (Basic) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-142.95 | $-3.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | · | · | · | · | · | · | |
| Shares (Basic) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,195 | 2,774,370 | · | · | · | · | · | · | |
| Shares (Diluted) | 55,669,821 | 1,416,471 | 456,014 | 880,311 | 186,958 | 2,774,370 | · | · | · | · | · | · | |
| EBITDA | $-18M | $-15M | $-13M | $-16M | $-42M | $-11M | $-9M | $-8M | $-13M | $-21M | $-19M | $-17M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $10M | $12M | $12M | $10M | $713.0K | $5M | $6M | $7M | $15M | $5M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $5M | $5M | $8M | $15M | |
| Receivables | $0 | $0 | · | $0 | $0 | $59.0K | $21.1K | $294.1K | $312.8K | $10.5K | $37.3K | $225.5K | |
| Prepaid Expense | $836.0K | $673.0K | $896.0K | $2M | $1M | $124.0K | $510.9K | $363.3K | $402.3K | $646.2K | $1M | $274.1K | |
| Current Assets | $134M | $10M | $13M | $15M | $12M | $896.0K | $6M | $7M | $12M | $21M | $13M | $28M | |
| PP&E (Net) | $0 | $3.0K | $10.0K | $10.0K | $3.0K | $5.0K | $41.0K | $90.3K | $172.9K | $269.6K | $343.2K | $301.3K | |
| PP&E (Gross) | · | · | · | · | · | $916.0K | $991.5K | $992.6K | $994.8K | $994.3K | $971.8K | $784.5K | |
| Accum. Depreciation | · | · | · | · | · | $905.2K | $950.4K | $902.3K | $821.9K | $724.8K | $628.6K | $483.2K | |
| Intangibles | · | · | · | · | · | $147.1K | $668.9K | $763.5K | $883.5K | $990.2K | $1M | $1M | |
| Other Non-current Assets | $68.0K | $273.0K | $490.0K | $694.0K | $868.0K | · | · | $24.0K | $13.9K | $15.7K | $71.8K | $58.7K | |
| Total Assets | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Accounts Payable | $767.0K | $1M | $698.0K | $2M | $1M | $3M | · | · | · | · | · | · | |
| Accrued Liabilities | $2M | $1M | $831.0K | $574.0K | $463.0K | $3M | · | · | · | · | · | · | |
| Current Liabilities | $5M | $3M | $3M | $3M | $2M | $8M | $1M | $1M | $2M | $7M | $6M | $4M | |
| Capital Leases | · | $0 | $90.0K | $211.0K | $0 | $112.0K | $148.5K | · | · | · | · | · | |
| Other Non-current Liabilities | · | $150.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $3M | $3M | $3M | $5M | $10M | $1M | $2M | $5M | $11M | $10M | $12M | |
| Long-term Debt | · | · | · | · | $87.0K | $1M | · | · | · | · | $8M | $9M | |
| Total Debt | · | · | · | · | $87.0K | · | · | · | · | $4M | $8M | $9M | |
| Common Stock | $2M | $27.0K | $6.0K | $30.0K | $3.0K | $28.0K | $38.7K | $9.1K | $151.6K | $110.3K | $70.8K | $877.9K | |
| Paid-in Capital | $281M | $143M | $133M | $122M | $102M | $51M | $227M | $220M | $217M | $204M | $177M | $168M | |
| Retained Earnings | · | $136M | $122M | $109M | $95M | $-68M | $-222M | $-214M | $-209M | $-193M | $-172M | $-151M | |
| AOCI | · | · | · | · | · | $-734 | $-6.2K | $-413 | $2.6K | $3.9K | $3.1K | $6.0K | |
| Stockholders' Equity | $129M | $7M | $11M | $12M | $7M | $-17M | $-8M | $6M | $9M | $11M | $5M | $18M | |
| Liabilities + Equity | $134M | $11M | $14M | $16M | $13M | $3M | $7M | $8M | $14M | $23M | $15M | $30M | |
| Shares Outstanding | 159,444,017 | 2,768,646 | 618,056 | 2,944,306 | 284,780 | 2,774,502 | 3,866,457 | 910,253 | 15,160,014 | 11,032,858 | 7,077,362 | 87,789,679 |
现金流 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3.0K | $2.0K | $3.0K | $143.9K | $185.8K | $289.2K | $337.5K | $345.5K | $348.6K | |
| Stock-based Comp | $4M | $652.0K | $624.0K | $1M | $2M | $2M | $880.8K | $634.1K | $2M | $3M | $3M | $4M | |
| Deferred Tax | · | · | · | · | $0 | $0 | $456.0K | $-3M | $19M | $-7M | $-8M | $-6M | |
| Amort. of Intangibles | · | · | · | · | · | $63.0K | $95.0K | $102.0K | $189.0K | $176.0K | $197.0K | $211.0K | |
| Operating Cash Flow | $-11M | $-12M | $-11M | $-13M | $-15M | $-5M | $-7M | $-8M | $-13M | $-16M | $-19M | $-12M | |
| CapEx | · | $0 | $4.0K | $10.0K | $0 | $6.0K | · | $1.7K | $11.4K | $98.1K | $176.3K | $207.9K | |
| Investing Cash Flow | · | $0 | $-4.0K | $-10.0K | $-54.0K | $-6.0K | · | $5M | $-94.0K | $2M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $4M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $-4M | $-5M | $-1M | $2M | |
| Stock Issued | $128M | $8M | $9M | $14M | $5M | $1M | · | · | · | · | $3M | · | |
| Net Stock Activity | $128M | $8M | $9M | $14M | $5M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $134M | $10M | $11M | $15M | $25M | $2M | $7M | $2M | $5M | $24M | · | · | |
| Net Change in Cash | $124M | $-3M | $49.0K | $2M | $10M | $-3M | $-672.2K | $-887.8K | $-9M | $10M | $-8M | $-4M | |
| Free Cash Flow | · | $-12M | $-11M | $-13M | $-15M | · | · | $-8M | $-13M | $-16M | $-19M | $-12M |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| Net Margin | · | · | -4920.0% | · | · | -120316.7% | -54252.6% | -1894.1% | -6025.4% | -129721.8% | -200671.0% | -120154.7% | |
| EBITDA Margin | · | · | -5228.0% | · | · | -78961.1% | -56071.8% | -3176.7% | -5118.1% | -127027.2% | -183896.8% | -92581.4% | |
| ROA | -23.1% | -115.8% | -82.5% | -100.9% | -342.8% | -165.7% | -117.1% | -45.7% | -85.9% | -112.2% | -93.1% | -91.9% | |
| ROE | -25.4% | -204.8% | -96.9% | -114.5% | -471.7% | 1056.6% | -137.3% | -93.5% | -157.9% | -258.6% | -184.3% | -173.2% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 | 4.0 | 4.6 | 6.2 | 8.2 | 2.9 | 2.1 | 7.0 | |
| Quick Ratio | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 | 3.3 | 4.2 | 5.8 | 7.9 | 2.8 | 1.9 | 6.9 | |
| Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | 0.3 | 1.6 | 0.5 | |
| LT Debt / Equity | · | · | · | · | 0.0 | · | · | · | · | · | 0.7 | 0.5 | |
| Interest Coverage | · | -1238.2 | -871.3 | -1209.3 | -17.5 | -761.7 | -967.7 | -1072.9 | -83.7 | -18.1 | -10.5 | -10.8 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 0.2 | 0.1 | 0.9 | 1.6 | 0.7 | 0.1 | 0.2 |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue CAGR 3Y | · | · | 164.4% | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $250.0K | $0 | $13.5K | $13.5K | $15.4K | $260.0K | $260.0K | $16.2K | $10.4K | $18.8K | |
| Net Income TTM | $-17M | $-14M | $-12M | $-14M | $-27M | $-10M | $-8M | $-5M | $-16M | $-21M | $-21M | $-23M | |
| Market Cap | $375M | $5M | $82M | $230M | $13.88B | $68.49B | $17.23B | $507.92B | $2.35T | $3.49T | $110.88T | $279.38T | |
| Enterprise Value | · | · | · | · | $13.87B | · | · | · | · | $3.49T | $110.88T | $279.38T | |
| P/E | -7.8 | -0.2 | -0.3 | -4.7 | -5.7 | -1064.5 | · | · | · | · | · | · | |
| P/S | · | · | 328.2 | · | 1026863.7 | 5065901.2 | 1118946.7 | 1953543.0 | 9026039.1 | 214531567.3 | 10643762608.8 | 14834698372.5 | |
| P/B | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | 7011.8 | 3360.3 | 83960.2 | 275600.1 | 307594.0 | 22321294.5 | 15767062.3 | |
| P / Tangible Book | 2.9 | 0.6 | 7.3 | 18.4 | 1885.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -34.5 | -0.4 | -7.4 | -17.2 | -939.8 | -7588.9 | -2374.0 | -66028.8 | -174921.1 | -223184.9 | -5856646.5 | -23865150.8 | |
| P / FCF | · | -0.4 | -7.4 | -17.2 | -939.8 | · | · | -66014.1 | -174772.6 | -221791.8 | -5802618.5 | -23448736.8 | |
| EV / EBITDA | · | · | · | · | -331.5 | · | · | · | · | -168885.5 | -5787900.1 | -16023415.6 | |
| EV / FCF | · | · | · | · | -939.1 | · | · | · | · | -221790.8 | -5802618.3 | -23448735.3 | |
| EV / Revenue | · | · | · | · | 1026093.9 | · | · | · | · | 214530552.3 | 10643762204.9 | 14834697377.5 | |
| Earnings Yield | -12.8% | -617.6% | -305.2% | -21.2% | -17.4% | -0.09% | · | · | · | · | · | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $250.0K | $0 | $0 | |
| R&D Expense | $6M | $6M | · | · | · | · | $0 | $16M | · | · | $362.0K | · | · | · | · | · | |
| SG&A Expense | $5M | $4M | $4M | $2M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Operating Expenses | $12M | $11M | $10M | $3M | $3M | $2M | $3M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | |
| Operating Income | $-12M | $-11M | $-10M | $-3M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-3M | $-4M | $-4M | $-3M | $-4M | $-4M | |
| Interest Expense | · | · | · | $5.0K | $2.0K | $1.0K | · | $6.0K | $2.0K | $1.0K | $4.0K | $8.0K | $3.0K | $0 | $3.0K | $4.0K | |
| Other Non-op | $1M | $1M | $1M | $59.0K | $61.0K | $81.0K | $41.0K | $112.0K | $133.0K | $147.0K | $187.0K | $190.0K | $219.0K | $189.0K | $131.0K | $426.0K | |
| Net Income | $-11M | $-10M | $-9M | $-3M | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-3M | $-4M | $-3M | $-2M | $-4M | $-4M | |
| EPS (Basic) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $1.13 | $-0.38 | $-0.58 | $-0.47 | $0.04 | $-2.32 | $-3.32 | $-4.59 | $-3.57 | $-7.38 | $-7.93 | $-8.13 | $6.30 | $-4.10 | |
| Shares (Basic) | 211,381,969 | 209,663,966 | 38,603,081 | 7,473,898 | 4,797,196 | 4,795,646 | -2,080,528 | 1,500,409 | 1,228,453 | 768,137 | -749,174 | 489,624 | 427,862 | 287,702 | -824,252 | 974,197 | |
| Shares (Diluted) | 211,381,969 | 209,663,966 | 38,603,081 | 7,473,898 | 4,797,196 | 4,795,646 | -2,080,528 | 1,500,409 | 1,228,453 | 768,137 | -749,174 | 489,624 | 427,862 | 287,702 | -824,252 | 974,197 | |
| EBITDA | $-12M | $-11M | · | $-3M | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-4M | $-4M | $-3M | · | $-4M |
资产负债表 19
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $133M | $133M | $5M | $5M | $7M | $10M | $8M | $11M | $11M | $12M | $15M | $16M | $13M | $12M | $14M | |
| Receivables | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | $250.0K | · | · | |
| Prepaid Expense | $2M | $615.0K | $836.0K | $2M | $1M | $657.0K | $673.0K | $830.0K | $959.0K | $737.0K | $896.0K | $954.0K | $1M | $762.0K | $2M | $1M | |
| Current Assets | $127M | $133M | $134M | $7M | $6M | $8M | $10M | $9M | $12M | $12M | $13M | $16M | $17M | $14M | $15M | $15M | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $2.0K | $3.0K | $3.0K | $4.0K | $5.0K | $10.0K | $10.0K | $11.0K | $9.0K | $10.0K | $12.0K | |
| Other Non-current Assets | $0 | $17.0K | $68.0K | $119.0K | $171.0K | $222.0K | $273.0K | $324.0K | $387.0K | $438.0K | $490.0K | $541.0K | $592.0K | $643.0K | $694.0K | $746.0K | |
| Total Assets | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Accounts Payable | $2M | $3M | $767.0K | $1M | $1M | $745.0K | $1M | $366.0K | $514.0K | $459.0K | $698.0K | $950.0K | $922.0K | $706.0K | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $831.0K | $794.0K | $598.0K | $309.0K | $574.0K | $1M | |
| Current Liabilities | $5M | $6M | $5M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $1M | $3M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $24.0K | $58.0K | $90.0K | $122.0K | $153.0K | $182.0K | $211.0K | $239.0K | |
| Other Non-current Liabilities | · | · | · | $283.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $4M | |
| Common Stock | $2M | $2M | $2M | $91.0K | $48.0K | $43.0K | $27.0K | $11.0K | $9.0K | $8.0K | $6.0K | $92.0K | $69.0K | $46.0K | $30.0K | $771.0K | |
| Paid-in Capital | $293M | $288M | $281M | $147M | $144M | $143M | $143M | $139M | $139M | $135M | $133M | $133M | $131M | $125M | $122M | $117M | |
| Retained Earnings | · | · | · | · | $141M | $138M | · | $133M | $-129M | $-125M | · | $118M | $115M | $112M | · | $105M | |
| Stockholders' Equity | $122M | $127M | $129M | $3M | $3M | $5M | $7M | $7M | $10M | $10M | $11M | $14M | $16M | $14M | $12M | $12M | |
| Liabilities + Equity | $127M | $133M | $134M | $7M | $7M | $8M | $11M | $9M | $13M | $13M | $14M | $17M | $18M | $15M | $16M | $16M | |
| Shares Outstanding | 173,595,201 | 167,421,702 | 159,444,017 | 9,119,152 | 4,800,247 | 4,396,646 | 2,768,646 | 1,198,516 | 966,345 | 851,302 | 618,056 | 9,210,751 | 6,849,362 | 4,563,977 | 2,944,306 | 77,080,169 |
现金流 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $2.0K | $1.0K | · | $0 | |
| Stock-based Comp | $5M | $4M | $4M | $90.0K | $69.0K | $69.0K | $77.0K | $95.0K | $362.0K | $118.0K | $185.0K | $202.0K | $144.0K | $93.0K | $86.0K | $252.0K | |
| Operating Cash Flow | $-8M | $-4M | $-3M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $10.0K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $-10.0K | $0 | |
| Stock Issued | $0 | $3M | $128M | $0 | $0 | $0 | $4M | $0 | $4M | $0 | $0 | $2M | $5M | $2M | $0 | $13M | |
| Net Stock Activity | · | $3M | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $147.0K | $3M | $131M | $3M | $4.0K | $-258.0K | $4M | $-180.0K | $4M | $2M | $-134.0K | $2M | $5M | $4M | $2M | $12M | |
| Net Change in Cash | $-7M | $-757.0K | $128M | $-190.0K | $-2M | $-3M | $2M | $-3M | $77.0K | $-1M | $-3M | $-1M | $3M | $914.0K | $-2M | $9M |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| Net Margin | -2114.8% | · | · | · | · | · | · | · | · | · | · | · | · | -936.0% | · | · | |
| EBITDA Margin | -2339.6% | · | · | · | · | · | · | · | · | · | · | · | · | -1011.6% | · | · | |
| ROA | -15.8% | -13.6% | · | -35.2% | -28.5% | -21.4% | · | -26.4% | -26.2% | -25.3% | · | -21.6% | -26.0% | -19.8% | · | -24.5% | |
| ROE | -17.0% | -14.5% | · | -58.4% | -44.3% | -29.0% | · | -33.7% | -31.7% | -29.6% | · | -27.1% | -33.9% | -25.2% | · | -48.8% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.3 | 23.7 | · | 2.0 | 1.6 | 2.8 | · | 3.3 | 4.3 | 4.9 | · | 6.1 | 7.5 | 10.9 | · | 4.3 | |
| Quick Ratio | 24.0 | 23.6 | · | 1.5 | 1.4 | 2.6 | · | 3.0 | 4.0 | 4.6 | · | 5.8 | 7.0 | 10.3 | · | 4.0 | |
| Interest Coverage | · | · | · | -584.4 | -1421.5 | -2310.0 | · | -598.8 | -2105.5 | -3673.0 | · | -472.2 | -1203.0 | · | · | -1103.2 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | 1.8 | · | · |
估值 (TTM) 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $250.0K | · | $250.0K | $250.0K | $250.0K | · | · | |
| Net Income TTM | $-26M | $-17M | · | $-11M | $-13M | $-13M | · | $-15M | $-15M | $-13M | · | $-13M | $-12M | $-13M | · | $-2M | |
| Market Cap | $363M | $293M | · | $8M | $3M | $3M | · | $4M | $4M | $5M | · | $80M | $175M | $241M | · | $5.78B | |
| P/E | -2.0 | -1.2 | · | -0.2 | -0.1 | -0.1 | · | -0.2 | -0.2 | -0.2 | · | -0.3 | -1.0 | -1.7 | · | -3.3 | |
| P/S | 725.6 | · | · | · | · | · | · | · | · | 20.4 | · | 320.5 | 698.6 | 963.9 | · | · | |
| P/B | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Tangible Book | 3.0 | 2.3 | · | 2.4 | 1.2 | 0.6 | · | 0.6 | 0.4 | 0.5 | · | 5.7 | 11.1 | 17.5 | · | 465.1 | |
| P / Cash Flow | · | -75.3 | · | · | · | -1.3 | · | · | · | -1.6 | · | · | · | -68.3 | · | · | |
| Earnings Yield | -50.7% | -84.6% | · | -436.1% | -983.8% | -1573.5% | · | -496.1% | -516.0% | -467.2% | · | -316.6% | -101.7% | -58.6% | · | -29.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $250.0K | $0 | — |
| 营业利润率 % | — | — | -5228.0% | — | — |
| 净收入 | $-17M | $-14M | $-12M | $-14M | $-27M |
| 稀释后每股收益 (EPS) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | — | — | 0.0 |
| 流动比率 | 29.0 | 3.2 | 5.2 | 4.9 | 5.0 |
| 速动比率 | 28.8 | 3.0 | 4.8 | 4.1 | 4.2 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | $-12M | $-11M | $-13M | $-15M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 125 家申报者 · $321.9M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 54 (+27 与上一季度对比) | 21 (+1 与上一季度对比) | 28 (-2 与上一季度对比) | 25 (+1 与上一季度对比) | +18.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | $27303106 | 13063687 | 8.48% | 股份 |
| B Group, Inc. | $23855856 | 11414285 | 7.41% | 股份 |
| AMERIPRISE FINANCIAL INC | $23160197 | 11081434 | 7.19% | 股份 |
| Octagon Capital Advisors LP | $21477503 | 10276317 | 6.67% | 股份 |
| JANUS HENDERSON GROUP PLC | $18759988 | 10689452 | 5.83% | 股份 |
| PERCEPTIVE ADVISORS LLC | $17608386 | 8425065 | 5.47% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $14889402 | 7124116 | 4.63% | 股份 |
| FRANKLIN RESOURCES INC | $12091045 | 5785189 | 3.76% | 股份 |
| Point72 Asset Management, L.P. | $10979612 | 5253403 | 3.41% | 股份 |
| Boxer Capital Management, LLC | $10031739 | 4799875 | 3.12% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $9405000 | 4500000 | 2.92% | 股份 |
| Eversept Partners, LP | $8742021 | 4182785 | 2.72% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $6639750 | 3175983 | 2.06% | 股份 |
| FEDERATED HERMES, INC. | $6555509 | 3136607 | 2.04% | 股份 |
| GOLDMAN SACHS GROUP INC | $6341647 | 3034281 | 1.97% | 股份 |
| Squadron Capital Management LLC | $6270000 | 3000000 | 1.95% | 股份 |
| Propel Bio Management, LLC | $5397191 | 2582388 | 1.68% | 股份 |
| Vestal Point Capital, LP | $5225000 | 2500000 | 1.62% | 股份 |
| STATE STREET CORP | $5174104 | 2475648 | 1.61% | 股份 |
| ORBIMED ADVISORS LLC | $4875970 | 2333000 | 1.51% | 股份 |
| GREAT POINT PARTNERS LLC | $4775272 | 2284819 | 1.48% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $4717352 | 2257106 | 1.47% | 股份 |
| HighVista Strategies LLC | $4244638 | 2030927 | 1.32% | 股份 |
| Siren, L.L.C. | $4180000 | 2000000 | 1.30% | 股份 |
| Artia Global Partners LP | $4164047 | 1992367 | 1.29% | 股份 |
| Aberdeen Group plc | $3992328 | 1910205 | 1.24% | 股份 |
| Balyasny Asset Management L.P. | $3920200 | 1875694 | 1.22% | 股份 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $3617510 | 1730866 | 1.12% | 股份 |
| ADAR1 Capital Management, LLC | $3608724 | 1726662 | 1.12% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3600688 | 1722817 | 1.12% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $3546013 | 1696657 | 1.10% | 股份 |
| Ally Bridge Group (NY) LLC | $2568610 | 1229000 | 0.80% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2350832 | 1124800 | 0.73% | 股份 |
| CITADEL ADVISORS LLC | $2125216 | 1016850 | 0.66% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2077659 | 994095 | 0.65% | 股份 |
| Nuveen, LLC | $2026165 | 969457 | 0.63% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $1952384 | 934155 | 0.61% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $1851556 | 885912 | 0.58% | 股份 |
| Ikarian Capital, LLC | $1567500 | 750000 | 0.49% | 股份 |
| VANGUARD GROUP INC | $1549329 | 659289 | 0.48% | 股份 |
| UBS Group AG | $1395238 | 667578 | 0.43% | 股份 |
| BIT Capital GmbH | $1199660 | 574000 | 0.37% | 股份 |
| Simplify Asset Management Inc. | $941635 | 450543 | 0.29% | 股份 |
| Creek Drive Management Group LLC | $919600 | 440000 | 0.29% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $913616 | 437137 | 0.28% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $909114 | 434983 | 0.28% | 股份 |
| MARSHALL WACE, LLP | $833471 | 398790 | 0.26% | 股份 |
| ACT CAPITAL MANAGEMENT, LLC | $642675 | 307500 | 0.20% | 股份 |
| Seven Fleet Capital Management LP | $568906 | 272204 | 0.18% | 股份 |
| RHUMBLINE ADVISERS | $336007 | 160773 | 0.10% | 股份 |
| DEUTSCHE BANK AG\ | $300960 | 144000 | 0.09% | 股份 |
| LPL Financial LLC | $297102 | 142154 | 0.09% | 股份 |
| XTX Topco Ltd | $272250 | 130263 | 0.08% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $264598 | 126602 | 0.08% | 股份 |
| WELLS FARGO & COMPANY/MN | $262435 | 125567 | 0.08% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $260604 | 124691 | 0.08% | 股份 |
| Bank of New York Mellon Corp | $251345 | 120261 | 0.08% | 股份 |
| Pale Fire Capital SE | $232847 | 111410 | 0.07% | 股份 |
| Verdad Advisers, LP | $208289 | 99660 | 0.06% | 股份 |
| SECTORAL ASSET MANAGEMENT INC | $183920 | 88000 | 0.06% | 股份 |
| MetLife Investment Management, LLC | $183659 | 87875 | 0.06% | 股份 |
| Squarepoint Ops LLC | $179694 | 85978 | 0.06% | 股份 |
| BANK OF AMERICA CORP /DE/ | $179291 | 85785 | 0.06% | 股份 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $172567 | 82568 | 0.05% | 股份 |
| EntryPoint Capital, LLC | $164061 | 78498 | 0.05% | 股份 |
| China Universal Asset Management Co., Ltd. | $141890 | 67890 | 0.04% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $141439 | 67674 | 0.04% | 股份 |
| CITIGROUP INC | $125438 | 60018 | 0.04% | 股份 |
| Invesco Ltd. | $123011 | 58857 | 0.04% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $122025 | 58385 | 0.04% | 股份 |
| Vanguard Global Advisers, LLC | $109290 | 52292 | 0.03% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $108764 | 52040 | 0.03% | 股份 |
| Quinn Opportunity Partners LLC | $104500 | 50000 | 0.03% | 股份 |
| Police & Firemen's Retirement System of New Jersey | $90978 | 43530 | 0.03% | 股份 |
| PCG Wealth Advisors, LLC | $85899 | 41100 | 0.03% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $83876 | 40132 | 0.03% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $69179 | 33100 | 0.02% | 股份 |
| WINTON GROUP Ltd | $67354 | 32227 | 0.02% | 股份 |
| Total Clarity Wealth Management, Inc. | $66452 | 31795 | 0.02% | 股份 |
| INTECH INVESTMENT MANAGEMENT LLC | $65110 | 31153 | 0.02% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $64591 | 30905 | 0.02% | 股份 |
| STRS OHIO | $60401 | 28900 | 0.02% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $58819 | 28143 | 0.02% | 股份 |
| TWO SIGMA SECURITIES, LLC | $57371 | 27450 | 0.02% | 股份 |
| Persistent Asset Partners Ltd | $54927 | 26281 | 0.02% | 股份 |
| ExodusPoint Capital Management, LP | $51332 | 24561 | 0.02% | 股份 |
| NORTHERN TRUST CORP | $48384 | 23150 | 0.02% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $47130 | 22550 | 0.01% | 股份 |
| PRUDENTIAL FINANCIAL INC | $46534 | 22265 | 0.01% | 股份 |
| BlackRock, Inc. | $46279 | 22143 | 0.01% | 股份 |
| NFSG Corp | $42323 | 20250 | 0.01% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $41292 | 19757 | 0.01% | 股份 |
| BARCLAYS PLC | $41139 | 19684 | 0.01% | 股份 |
| ProShare Advisors LLC | $40389 | 19325 | 0.01% | 股份 |
| Voleon Capital Management LP | $39390 | 18847 | 0.01% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $33247 | 29228 | 0.01% | 股份 |
| CHOREO, LLC | $32903 | 15743 | 0.01% | 股份 |
| MORGAN STANLEY | $32775 | 15682 | 0.01% | 股份 |
| Cetera Investment Advisers | $32408 | 15506 | 0.01% | 股份 |
| Legal & General Group Plc | $29935 | 14323 | 0.01% | 股份 |
公司内部人士 26 位内幕人士 · 9 位高管 · 21 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| John David Finley | CEO, CFO | 2026年7月7日 M | 217688 | 0 | 1 | $-303872 |
| Thomas Hallam | Chief Executive Officer | 2022年3月28日 P | 17592 | 0 | 0 | $0 |
| Richard J Daly | Chief Executive Officer | 2017年11月7日 A | 23312 | 0 | 0 | $0 |
| Richard Garr | CEO | 2016年1月27日 M | 1449804 | 0 | 0 | $0 |
| Jones Jonathan Brian Lloyd | Chief Financial Officer | 2017年3月24日 P | 7859 | 0 | 0 | $0 |
| John Conron | Chief Financial Officer | 2011年1月28日 A | 115492 | 0 | 0 | $0 |
| Mitchell Lawrence Jones | Chief Medical Officer | 2026年7月6日 M | 94009 | 0 | 1 | $-106354 |
| Michael John Dawson | Chief Medical Officer | 2022年3月29日 P | 15000 | 0 | 0 | $0 |
| Karl Johe | Chief Scientific Officer | 2015年11月19日 M | 930373 | 0 | 0 | $0 |
| Robert Baltera Jr. | 董事 | 2026年7月7日 P | 416904 | 4 | 0 | $161300 |
| Jordan Michael Zwick | 董事 | 2026年6月10日 A | 336904 | 0 | 0 | $0 |
| Emil Chuang | 董事 | 2026年6月10日 M | 612500 | 0 | 0 | $0 |
| Binxian Wei | 董事 | 2026年6月10日 M | 613355 | 0 | 0 | $0 |
| Donald Allen Williams | 董事 | 2026年6月10日 M | 1570294 | 0 | 0 | $0 |
| Stephanie Diaz | 董事 | 2021年11月18日 A | — | 0 | 0 | $0 |
| Robert J. Trenschel | 董事 | 2021年11月18日 A | 14999 | 0 | 0 | $0 |
| James R Neal | 董事 | 2021年11月18日 A | — | 0 | 0 | $0 |
| Cristina Csimma | 董事 | 2021年11月18日 A | — | 0 | 0 | $0 |
| Mary Ann Gray | 董事 | 2021年11月18日 A | — | 0 | 0 | $0 |
| David J Mazzo | 董事 | 2021年4月1日 A | — | 0 | 0 | $0 |
| William Clyde Oldaker | 董事 | 2019年7月1日 A | 33763 | 0 | 0 | $0 |
| Scott Varde Ogilvie | 董事 | 2019年7月1日 A | 86020 | 0 | 0 | $0 |
| Sandford D Smith | 董事 | 2019年7月1日 A | 219916 | 0 | 0 | $0 |
| Stanley Westreich | 董事 | 2018年7月2日 A | 143281 | 0 | 0 | $0 |
| Catherine A. Sohn | 董事 | 2015年7月1日 A | 106952 | 0 | 0 | $0 |
| REGAL ONE CORP | 10% 所有者 | 2007年3月13日 J | 1293814 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Yuma Regional Medical Center | 2021年8月30日 | — | 初始申报 | 并购/出售 | SEC |
| Tianjin Pharmaceuticals Group Holdings Co., Ltd, Tianjin Pharmaceuticals Group International Holdings Co., Ltd | 2017年2月27日 | — | 初始申报 | 被动投资 | SEC |
| Karl Johe ×2 申报 | 2015年2月4日 | — | 初始申报 | — | SEC |
| I.Richard Garr | 2015年2月4日 | — | 初始申报 | — | SEC |
| I. Richard Garr | 2014年3月6日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 11 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.07% | 502938 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 105506 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.02% | 1106561 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 847978 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.01% | 3653534 SH | 2026年8月8日 | 每日 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 80446 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.00% | 240420 SH | 2026年8月8日 | 每日 |
| ITOT · iShares Trust | 0.00% | 383544 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1722817 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 28274 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12337 SH | 2026年8月8日 | 每日 |